These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 18643871)
1. Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3. Wang Y; Zhang JX; Du XX; Zhao L; Tian Q; Zhu LQ; Wang SH; Wang JZ J Neurochem; 2008 Sep; 106(6):2364-74. PubMed ID: 18643871 [TBL] [Abstract][Full Text] [Related]
2. Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats. Peng JH; Zhang CE; Wei W; Hong XP; Pan XP; Wang JZ Neuropharmacology; 2007 Jun; 52(7):1521-7. PubMed ID: 17434540 [TBL] [Abstract][Full Text] [Related]
3. Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture. Li X; Lu F; Tian Q; Yang Y; Wang Q; Wang JZ J Neural Transm (Vienna); 2006 Jan; 113(1):93-102. PubMed ID: 15959856 [TBL] [Abstract][Full Text] [Related]
4. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner. Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188 [TBL] [Abstract][Full Text] [Related]
5. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. Liu SJ; Zhang AH; Li HL; Wang Q; Deng HM; Netzer WJ; Xu H; Wang JZ J Neurochem; 2003 Dec; 87(6):1333-44. PubMed ID: 14713290 [TBL] [Abstract][Full Text] [Related]
6. Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C. Jiang X; Tian Q; Wang Y; Zhou XW; Xie JZ; Wang JZ; Zhu LQ J Neurochem; 2011 Sep; 118(5):864-78. PubMed ID: 21689104 [TBL] [Abstract][Full Text] [Related]
7. Prolonged Alzheimer-like tau hyperphosphorylation induced by simultaneous inhibition of phosphoinositol-3 kinase and protein kinase C in N2a cells. Xu GG; Deng YQ; Liu SJ; Li HL; Wang JZ Acta Biochim Biophys Sin (Shanghai); 2005 May; 37(5):349-54. PubMed ID: 15880264 [TBL] [Abstract][Full Text] [Related]
8. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737 [TBL] [Abstract][Full Text] [Related]
9. Activation of GSK-3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats. Wang Y; Tian Q; Liu EJ; Zhao L; Song J; Liu XA; Ren QG; Jiang X; Zeng J; Yang YT; Wang JZ J Cell Mol Med; 2017 Dec; 21(12):3515-3528. PubMed ID: 28656644 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation. Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846 [TBL] [Abstract][Full Text] [Related]
11. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3. Koh SH; Noh MY; Kim SH Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715 [TBL] [Abstract][Full Text] [Related]
12. AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation. Li XH; Lv BL; Xie JZ; Liu J; Zhou XW; Wang JZ Neurobiol Aging; 2012 Jul; 33(7):1400-10. PubMed ID: 21450369 [TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3 reduces acetylcholine level in striatum via disturbing cellular distribution of choline acetyltransferase in cholinergic interneurons in rats. Zhao L; Chu CB; Li JF; Yang YT; Niu SQ; Qin W; Hao YG; Dong Q; Guan R; Hu WL; Wang Y Neuroscience; 2013; 255():203-11. PubMed ID: 24121130 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced tau phosphorylation and memory deficit in rats. Zhang CE; Yang X; Li L; Sui X; Tian Q; Wei W; Wang J; Liu G Neurodegener Dis; 2014; 14(3):107-16. PubMed ID: 24993525 [TBL] [Abstract][Full Text] [Related]
15. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice. Naert G; Ferré V; Meunier J; Keller E; Malmström S; Givalois L; Carreaux F; Bazureau JP; Maurice T Eur Neuropsychopharmacol; 2015 Nov; 25(11):2170-82. PubMed ID: 26381812 [TBL] [Abstract][Full Text] [Related]
16. Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of tau and spatial memory deficit in rat. Sun L; Wang X; Liu S; Wang Q; Wang J; Bennecib M; Gong CX; Sengupta A; Grundke-Iqbal I; Iqbal K FEBS Lett; 2005 Jan; 579(1):251-8. PubMed ID: 15620722 [TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β. Wang XL; Zeng J; Yang Y; Xiong Y; Zhang ZH; Qiu M; Yan X; Sun XY; Tuo QZ; Liu R; Wang JZ J Alzheimers Dis; 2015; 43(1):153-65. PubMed ID: 25079798 [TBL] [Abstract][Full Text] [Related]
18. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells. Hu M; Waring JF; Gopalakrishnan M; Li J J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099 [TBL] [Abstract][Full Text] [Related]
19. Effects of endogenous beta-amyloid overproduction on tau phosphorylation in cell culture. Wang ZF; Li HL; Li XC; Zhang Q; Tian Q; Wang Q; Xu H; Wang JZ J Neurochem; 2006 Aug; 98(4):1167-75. PubMed ID: 16762022 [TBL] [Abstract][Full Text] [Related]
20. Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains. Tian M; Zhu D; Xie W; Shi J FEBS Lett; 2012 Oct; 586(20):3737-45. PubMed ID: 22982863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]